MT1 and MT2 melatonin receptors play opposite roles in brain cancer progression.
Kinker GS, Ostrowski LH, Ribeiro PAC, Chanoch R, Muxel SM, Tirosh I, Spadoni G, Rivara S, Martins VR, Santos TG, Markus RP, Fernandes PACM.
Kinker GS, et al. Among authors: muxel sm.
J Mol Med (Berl). 2021 Feb;99(2):289-301. doi: 10.1007/s00109-020-02023-5. Epub 2021 Jan 3.
J Mol Med (Berl). 2021.
PMID: 33392634